Omalizumab: a novel steroid sparing agent in eosinophilic granulomatosis with polyangiitis?

MeSH terms

• Adult
• Anti-Asthmatic Agents / adverse effects
• Anti-Asthmatic Agents / therapeutic use*
• Antibodies, Anti-Idiotypic / adverse effects
• Antibodies, Anti-Idiotypic / therapeutic use*
• Antibodies, Monoclonal, Humanized / adverse effects
• Antibodies, Monoclonal, Humanized / therapeutic use*
• Asthma / drug therapy*
• Churg-Strauss Syndrome / drug therapy*
• Drug Substitution
• Humans
• Immunosuppressive Agents / adverse effects
• Immunosuppressive Agents / therapeutic use*
• Male
• Omalizumab
• Remission Induction
• Steroids / adverse effects
• Steroids / therapeutic use*
• Treatment Outcome